Medical

Technology for SAVING BRAIN AND LIVES

  • This technology is a NOVEL PLATFORM TECHNOLOGY for DRUG DELIVERY SYSTEM for CARDIOVASCULAR DISEASES; NEUROLOGIC DISEASES; CANCER and INFECTIOUS DISEASES.
  • Getting Drugs to Their Targets in a Controlled Manner: Many drugs even with the most advanced molecular biology strategies have unacceptable side effects. Due to the drug interacting with healthy tissues that are not the target of the drug.
  • UNMET CLINICAL NEED  in ACUTE ISCHEMIC STROKE (AIS) and ACUTE PULMONARY EMBOLI – 2 leading, devastating diseases with high mortality and disability. Both are the result of a blood clot (thrombosis) in an artery. Because brain tissue rapidly dies, time to reperfusion is critical in both preventing death and improving neurological outcomes.
  • rtPA -THROMBOLITIC THERAPY WITH TISSUE PLASMINOGEN ACTIVATOR is the proven treatment for acute ischemic stroke, pulmonary emboli, heart attack and vascular occlusion. BUT, the success rate is less than 30% and Bleeding and Mortality from TPA are more than 5%.
  • WHAT THE COMPAMY DOES: NANOMAGNETIC DRUG DELIVERY

 Combine Superparamagnetic Nanoparticles (SPION) made of iron oxide Loaded with tPA  (~100 nanometer).

An external Electromagnetic Workstation targets the drug right into the clotted artery.

  • VALUE PROPOSITION
  • Effective dose reduction (>90%).
  • Fast targeting and entry into the clot.
  • Controlled release of drug with much improved results.
  • Less bleeding and death complication.
  • Improved stroke recovery reduced mortality.
  • Saving $$$Billions for hospital stay and rehabilitation.
  • Market of millions of patients/year.